Screening for circulating tumor DNA from peripheral blood is low invasive and provides fast results, and we suggest screening for HPVP HNSCC using a panel, including RBM24, INHBA, SYCP2, TAFL7, and ZFR2. The gene discussed is SYCP2; the disease is head and neck squamous cell carcinoma.